Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...

AUSTIN (KXAN) — Is there a band or singer your parents listened to while you were growing up who influenced your music choices? For Austinite Vanda Taupradis t, it was Stevie Wonder. The icon ...

Investing.com -- Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock jumped 5.1% Monday after the company announced it submitted a Biologics License Application (BLA) to the FDA for imsidolimab, a treatment ...

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) requesting ...

Vanda Pharmaceuticals is trading materially below its holdings of cash and marketable securities (worth almost $7/share). Multiple FDA approvals, if forthcoming, in 2024 could prove to be material ...

Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...

Tradipitant could become the first new pharmacologic treatment for motion sickness in over 40 years.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is one of the stocks on Jim Cramer’s radar recently. When Cramer was asked about the stock toward the end of the lightning round, he said: “Well, look, here’s ...

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose 11% in after-hours trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has lifted a partial ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) reported positive results in a Phase III study of Fanapt in the treatment of acute manic and mixed episodes associated with bipolar I disorder in adults.